NJOY Netherlands v Juul Labs International (CFI, 28 February 2025)
| Date | 28 February 2025 |
|---|---|
| Court | CFI |
| Division | Paris (FR) Central Division - Seat |
| Type of action | Revocation Action |
| Case number(s) | UPC_CFI_312/2023 |
| Registry reference | 571761/2023 · ORD_10060/2025571761/2023 · UPC_CFI_312/2023 |
| Parties | NJOY Netherlands B.V. / v / Juul Labs International Inc. |
Official decision (PDF) · UPC registry entry
Dhenne Avocats represents claimants and defendants in European patent disputes before the Unified Patent Court, including the Paris divisions.
Dhenne Avocats · 10 October 2026
Our analysis
Summary
By decision of 28 February 2025, the Paris Central Division, ruling on NJOY Netherlands’ revocation action against Juul Labs International’s EP 3 504 989 (“Vaporization device systems”), holds that claim 1 as granted contains added matter, but maintains the patent as amended by Auxiliary Request I filed on 22 July 2024, for Belgium, France, Germany, Italy, the Netherlands, Portugal and Sweden. Each party bears its own costs. The decision shows a strict application of the bar on intermediate generalisation: a feature taken from an embodiment cannot be isolated where it is intrinsically linked to another element, but the proprietor may cure the defect by reintroducing only the functionally linked element, without importing the whole figure.
Facts and procedure
The revocation action was filed on 15 September 2023. Juul’s preliminary objection was rejected, and that rejection was upheld by the Court of Appeal. The patent derives from a divisional application filed on 15 February 2019 from the international application published as WO 2015/100361, oppositions were pending at the EPO when the action was filed, NJOY not being a party to them. Juul reduced its 55 auxiliary requests to eight, which the division admitted (paragraph 9.3). NJOY relied on added matter, lack of novelty and lack of inventive step, in particular over Chen (CN 101843368 A) and Cohen (US 2011/0036346 A1).
The applicable law
The grounds for revocation fall under Art. 138(1)(a) and (c) EPC, read with Arts. 52, 54, 56, 76(1) and 123(2) EPC. Claims are construed under Art. 69 EPC and its Protocol (paragraphs 7.2 to 7.6). Added matter is assessed by asking what is directly and unambiguously derivable from the application as filed (paragraph 8.2). The procedure is front-loaded: the claimant must present its case in the statement for revocation, although a generous standard applies to replies to the other side’s arguments (paragraphs 5.3 and 5.4).
Question
Does claim 1, which requires a channel air inlet to be left exposed, have a basis in the application as filed without the feature of the notch in the device body, and is Auxiliary Request I allowable, novel and inventive?
Decision
The division holds that the basis relied on by Juul, claim 159 and paragraph [00170] of WO 2015/100361, is insufficient: claim 159 contains no notch, and paragraph [00170] and Figure 14 intrinsically link the exposure of the air inlet to the notch, whereas granted claim 1 separates them (paragraphs 8.5 to 8.13). The argument that the notch may be varied is rejected and the patent cannot be maintained as granted (paragraphs 8.15 and 8.16). Auxiliary Request I, which specifies that the size of the air inlet is defined by the configuration of the notch, is allowable: the other elements of Figure 14 (battery, circuit board, sensor) are not linked to the air inlet, and “configuration” covers size and shape without requiring any particular notch (paragraphs 9.4 to 9.16). It is novel over Chen, whose semicircular holes are not a notch exposing a separate inlet, and over Cohen (paragraphs 9.17 to 9.37), and NJOY fails to establish obviousness (paragraphs 9.38 to 9.41). On procedure, the division admits the Hajaligol expert declaration and the rejoinder, but excludes pages 4 to 14 of NJOY’s submission of 22 April 2024 and Juul’s submission of 31 May 2024 (paragraphs 5.6 to 5.17). Each party bears its own costs under Art. 69(2) UPCA and Rule 118.5 (paragraph 11.1).
Key points for practice
- A feature taken from an embodiment cannot be claimed in isolation where the description intrinsically links it to another element. Only the functionally linked element needs to be reintroduced, however (paragraphs 8.11 to 8.13 and 9.7 to 9.9).
- Cutting a large number of auxiliary requests down to a short set during the proceedings is accepted under Rule 9.2 (paragraph 9.3).
- Front-loading does not prevent a party from answering the other side’s arguments, but submissions going beyond that scope may be excluded in whole or in part (paragraphs 5.4 and 5.15 to 5.17).
- Practical point: proprietors should prepare auxiliary requests that reintroduce the structural element inseparable from the challenged feature, without importing the entire embodiment.
Provisions applied
- Agreement on a Unified Patent Court
- Arts. 69(2), 73(1) and 82
- Rules of Procedure
- Rules 9.1, 9.2, 19.1(a), 32.3, 36, 43.3, 44, 48, 52, 55, 58, 118.5, 220.1(a) and 224.1(a)
- European Patent Convention
- Arts. 52, 54, 56, 69, 76, 84, 123 and 138
- Case law cited
- NanoString v 10x Genomics, Court of Appeal, 26 February 2024, VusionGroup v Hanshow, Court of Appeal, 13 May 2024, Umedwings v Abbott Diabetes Care, The Hague Local Division, 19 June 2024
Prepared by Dhenne Avocats from the official decision, consulted on 10 October 2026. The database is updated every week, on Friday. Only the official text is authoritative.
Going further
Lexicon: Revocation action.
Publications by Matthieu Dhenne: G 1/25, Take Three: Anything You Leave in the Description May Be Used Against You (Kluwer Patent Blog).
Source and translations
- Official source
- Unified Patent Court registry link recorded in the record
- Original language
- not recorded
- Translation available
- no translation recorded the firm’s French record is a summary, not a translation
- Date checked
- not recorded
Follow this case
Proceedings, related decisions, appeals, parties and patents as recorded in the registry and in the Dhenne Avocats corpus. Each link states its source.
Parties
- claimantv14 decisions in the corpusFollow this party
- claimantJuul Labs International Inc.4 decisions in the corpusFollow this party
- claimantNJOY Netherlands B.V.20 decisions in the corpusFollow this party
Decisions in the same proceedings and documented appeals
What the record states
- Nature of the act
- Revocation Action
- Outcome (Dhenne Avocats summary)
- La division centrale, section de Paris, juge que la revendication 1 telle que délivrée étend l’objet de la demande initiale, mais maintient le brevet de Juul sous la forme de la requête subsidiaire I, nouvelle et inventive. Chaque partie conserve ses frais.
- Appeal
- No appeal documented in the corpus, this does not mean that no appeal was lodged.
- Instance
- First-instance decision, whether it has become final is not recorded.
Patents mentioned
EP 3 504 989mentioned in: Dhenne Avocats analysis Follow this patent
Related decisions cited in the analyses
- Abbott Diabetes Care v Sibio Technology (CFI, UPC_CFI_131/2024, 19 June 2024) cited in this record
- SES-imagotag v Hanshow (CoA, 13 May 2024) cited in this record
- NanoString Technologies v 10x Genomics (CoA, 26 February 2024) cited in this record
- Meril Life Sciences v Edwards Lifesciences (CFI, 20 October 2025) cites this decision
Patents and standards
| Publication | Role in the dispute | Family | Standard and declaration | Pool | Sources |
|---|---|---|---|---|---|
EP 3 504 989 | Mentioned in the analysis (role not qualified) | not recorded | not recorded | not recorded | Espacenet links not checked mentioned in: Dhenne Avocats analysis |
Receive an alert
Weekly summary of new records and substantive updates matching what you follow. Address confirmed by email, unsubscribe at any time, one email per week even where several of your follows match.